Tango Therapeutics Stock (NASDAQ: TNGX) stock price, news, charts, stock research, profile.
Open | $7.710 |
Close | $7.940 |
Volume / Avg. | 1.254M / 670.778K |
Day Range | 7.625 - 7.990 |
52 Wk Range | 2.470 - 13.030 |
Market Cap | $847.343M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 14.28% |
Days to Cover | 10.68 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tango Therapeutics (NASDAQ: TNGX) through any online brokerage.
Other companies in Tango Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), ARS Pharmaceuticals (NASDAQ:SPRY), Cabaletta Bio (NASDAQ:CABA), Fate Therapeutics (NASDAQ:FATE) and Kyverna Therapeutics (NASDAQ:KYTX).
The latest price target for Tango Therapeutics (NASDAQ: TNGX) was reported by HC Wainwright & Co. on Wednesday, March 20, 2024. The analyst firm set a price target for 17.00 expecting TNGX to rise to within 12 months (a possible 114.11% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Tango Therapeutics (NASDAQ: TNGX) is $7.94 last updated March 28, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Tango Therapeutics.
Tango Therapeutics’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Tango Therapeutics.
Tango Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.